Skip to main content

Preface [Hot topic: The Way Down from Single Genes and Proteins to Single Molecules (Guest Editors: Z. Foldes-Papp, J. Enderlein, J. Widengren and M. Kinjo)]

Buy Article:

$68.00 + tax (Refund Policy)

The collection of articles published under the motto “The way down from single genes and proteins to single molecules” is covering the results of groundbreaking developments of the recent years. They include single molecule detection yielding ultimate sensitivity and closely linked to the analysis of molecular noise by correlation spectroscopy. Several important examples from the field of nucleic acid as well as protein analysis as diagnostic tools are presented as well as the impact on the studies of single cells and biomembranes. The development of high sensitivity analysis at the single molecule level has in turn prompted the development of high-throughput protocols nowadays used in drug screening.

In the attempt to make the vast and still growing knowledge of the human genome available for understanding the ultimate cause of disease and their therapy, these four special issues will fulfill a very important goal.

Document Type: Book Review

Affiliations: Stockholm.

Publication date: 01 February 2004

More about this publication?
  • Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content